Skip To Main Content
Pascal Hickey on Muck Rack

Pascal Hickey

As seen in: Color Research & Application, Clinical and Translational Allergy, The Journal of Allergy & Clinical Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Pascal Hickey’s profile

Articles by Pascal Hickey

Immunological changes in peripheral blood following nasal allergen challenge in subjects with allergic rhinitis pre‐ and post‐peptide immunotherapy: An open‐label clinical study

|
By young kim, Elena Tonti, Pascal Hickey, Anne Ellis
| Wiley Online Library Verified
LETTER TO THE EDITOR Young Woong Kim, orcid.org/0000-0002-3470-6728 Experimental Medicine, University of British Columbia, Vancouver, BC, Canada Prevention of Organ Failure (PROOF) Centre of Excellence, Vancouver, BC, Canada Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, BC, Canada Search for more papers by this author Elena Tonti, Department of Medicine, McMaster University, Hamilton, ON, Canada Search for more papers by this author Pascal Hickey, Adiga Life Sciences,...
Open in Who Shared Issue with article?

Safety and Tolerability of a Novel Peptide-Based Immunotherapy for Peanut Allergy

|
By Sara R. Prickett, Pascal Hickey, Judy Bingham, Tracy Phan
| The Journal of Allergy & Clinical Immunology Verified
Open in Who Shared Issue with article?

The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy

|
By Helen Neighbour, Mena Soliman, Lisa Steacy Verified, Pascal Hickey
| Clinical and Translational Allergy Verified
Allergic Rhinitis (AR) is an inflammatory disease of the nasal mucosa, manifesting in symptoms of rhinorrhea, sneezing, nasal congestion and itch as a result of exposure to specific allergens [1]. According to the Allergic Rhinitis and its Impact on Asthma (ARIA) report, it is conservatively estimated that five hundred million people suffer from AR globally [1].
Open in Who Shared Issue with article?
Show More